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approach. The solution, instead, is to work out what is specificity, and the ease with which radioactive or fluo-
happening at the molecular level. How can this effect rescent labels are incorporated made the a neurotoxins
be induced or mimicked in axons without a conditioning indispensable experimental tools for the study of
lesion? Can it be induced in neurons that do not have nAChRs. Their use immediately led to the identification,
a peripheral nerve branch? Why did the dorsal column purification, and localization of these receptors in mus-
axons stop growing before they reached their original cle and in the Torpedo electric organ, and made the
target? Perhaps the initial signal induced by the condi- nAChR the paradigmatic neurotransmitter receptor for
tioning lesion had subsided. If so, would a second lesion the next 20 years.
encourage them to start growing again? Answers to aBtx is an effective toxin because it inhibits the bind-
these questions could lead to a rational, molecular ap- ing of acetylcholine to the AChR, producing neuromus-
proach to encouraging CNS axons to regrow after injury. cular blockade and quick death. This efficient strategy
The next problem, of course, is then getting them to is used by a large number of poisonous snakes in the
their correct destination. Elapidae family (cobras, kraits, mambas, and tiger snakes,
among others), whose venoms collectively contain over
100 toxins with sequence homology to aBtx. All of theseMarie T. Filbin
toxins share a common structure consisting of a b sheetDepartment of Biological Sciences
core that is tightly cross-linked by four invariant disulfideHunter College of the City University of New York
bonds. Three flexible loops extend from the core to bindNew York, New York 10021
the receptor (Love and Stroud, 1986). Most of the toxins
in the family bind the nAChR, but some bind other mole-Selected Reading
cules, including muscarinic AChRs and acetylcholines-
terase.Bregman, B.S., Kunkel-Bagden, E., Schnell, L., Dai, H.N., Gao, D.,
and Schwab, M.E. (1995). Nature 378, 498±501. The idea that potent toxins have evolved to recognize
Cai, D., Shen, Y., De Bellard, M.E., Tang, S., and Filbin, M.T. (1999). physiological binding sites for a natural ligand such as
Neuron 22, 89±101. acetylcholine is a familiar one. Recent studies by Miwa
David, S., and Aguayo, A.J. (1981). Science 214, 931±933. et al. (1999), however, reported in this issue of Neuron,
DeBellard, M.E., Tang, S., Mukhopadhyay, G., Shen, Y., and Filbin, give this concept a new twist. They suggest that the a
M.T. (1996). Mol. Cell. Neurosci. 7, 89±101. neurotoxins not only mimic but also may be evolution-
McQuarrie, I.G., and Grafstein, B. (1973). Exp. Neurol. 29, 53±55. arily related to an endogenous ligand for the AChR, one
Neumann, S., and Woolf, C.J. (1999). Neuron 23, this issue, 83±91. that enhances rather than inhibits the action of acetyl-
Oudega, M., Varon, S., and Hagg, T. (1994). Exp. Neurol. 129, choline. This new finding not only sheds light on the
194±206. evolutionary origins of this family of toxins, but also
Richardson, P.M., and Issa, V.M.K. (1984). Nature 309, 791±793. poses the question of how the endogenous peptide
Richardson, P.M., McGuinness, U.M., and Aguayo, A.J. (1980). Na- might function physiologically to modulate the AChR.
ture 284, 264±265.
The beneficent new relative of the family of elapid
Shewan, D., Berry, M., and Cohen, J. (1995). J. Neurosci. 15, 2057±
neurotoxins is lynx1, a small (11 kDa) protein that was2062.
identified in the course of a search for developmentallySmith, D.S., and Skene, J.H.P. (1997). J. Neurosci. 17, 646±658.
regulated genes in the cerebellum. A database search
Song, H., Ming, G., Lehmann, M., McKerracher, L., Tessier-Lavigne,
using the amino acid sequence encoded by the lynx1M., and Poo, M.-M. (1998). Science 281, 1515±1518.
gene immediately revealed homology with aBtx and with
the Ly-6 family, a related group of proteins that are found
on the surface of mouse lymphocytes (Gumley et al.,
1995). The Ly-6 proteins have tertiary structures that
are similar to aBtx and are apparently attached to thea Neurotoxins and Their Relatives: surface membrane through a glycolipid anchor, where
Foes and Friends? they participate in cell±cell and cell±substrate interac-
tions. lynx1 shares with both aBtx and Ly-6 the highly
conserved motif of eight cysteines, and models show
that its predicted three-dimensional structure closelyIn 1963, C. C. Chang and C. Y. Lee initiated a new era
resembles the experimentally determined structures ofin the study of neurotransmitter receptors by showing
aBtx and CD59, a member of the Ly-6 family. Moreover,that a small protein toxin derived from the Taiwanese
the exon±intron boundaries of all three proteins are thesnake Bungarus multicinctus bound tightly and specifi-
sameÐa strong indication of a common evolutionarycally to the nicotinic acetylcholine receptor (nAChR) at
origin.the vertebrate neuromuscular junction (Chang and Lee,
What distinguishes lynx1, and makes it of unusual1963). At the time of the discovery of a-bungarotoxin
interest, is evidence suggesting that it has a functional(aBtx) and its cobratoxin relatives, the nAChR, although
relationship to AChRs in the nervous system. lynx1 isphysiologically and pharmacologically well defined, was
highly expressed in the brain, where it is associated witha molecular enigma. Even the question of whether it was
neurons in the cortex, in the hippocampus, and in thea protein was disputed. The advent of aBtx and related
cerebellum. Interestingly, each of the sites of lynx1 local-a neurotoxins completely transformed the field. Their
ization in the brain is also a site at which the a7 neuronalextremely high affinity and long off-times (making them
essentially irreversible antagonists), their extraordinary AChR is expressed. The a7 AChR, a homooligomeric
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Selected Readingchannel protein, is the only neuronal AChR in the mam-
malian brain with an appreciable affinity for aBtx (Lind-
Barmack, N.H., Baughman, R.W., and Eckstein, F.P. (1992). J. Comp.strom, 1996). (In the avian brain another subunit, a8, Neurol. 317, 233±249.
also binds aBtx.) In the cerebellum, lynx1 is associated
Caruncho, H.J., Guidotti, A., Lindstrom, J., Costa, E., and Pesold,
with the cell bodies and proximal dendrites of Purkinje C. (1997). Neuroreport 8, 1431±1433.
cells, which are sites of a7 localization and cholinergic Chang, C.C., and Lee, C.Y. (1963). Arch. Int. Pharmacodyn. 144,
innervation from mossy fibers (Barmack et al., 1992; 241±257.
Caruncho et al., 1997). This provocative colocalization Gumley, T.P., McKenzie, I.F.C., and Sandrin, M.S. (1995). Immunol.
Cell Biol. 73, 277±296.prompted Miwa et al. (1999) to look for a functional
interaction by expressing the a7 subunit in oocytes. Lindstrom, J. (1996). In Ion Channels, T. Narahashi, ed. (New York:
Plenum Press), pp. 377±450.They found by electrophysiological recording that addi-
Love, R.A., and Stroud, R.M. (1986). Prot. Eng. 1, 37±46.tion of recombinant lynx1 increased the response of the
Stallcup, W.B., and Patrick, J. (1980). Proc. Natl. Acad. Sci. USA 77,a7 AChR to acetylcholine. These interesting findings
634±638.suggest that lynx1 might have a role in modulating ACh
Unwin, N. (1993). J. Mol. Biol. 229, 1101±1124.activity in the nervous system and might do so by direct
interaction with the AChR.
Several questions remain, however. First, direct inter-
action of lynx1 with the AChR has yet to be demon-
strated. Miwa et al. (1999) found that lynx1 facilitated
the action of acetylcholine not only on the a7 AChR but
also on the a4b2 receptor, a neuronal AChR that is not
sensitive to aBtx (Lindstrom, 1996). Although lynx1 may
have a different specificity for AChRs than aBtx, this
finding at least raises the possibility that lynx1 affects
the AChR indirectly by acting through an entirely differ-
ent receptor. Direct interaction, if present, should be
easily demonstrable by showing that lynx1 can block
aBtx binding to the AChR, or that aBtx can block the
binding of the lynx1/Fc fusion protein used to demon-
strate lynx1 binding sites in cerebellar tissue sections.
Second, if lynx1 interacts directly with the AChR, how
does it act? There are few examples of peptides that
directly modulate neurotransmitter receptor function.
The effect of substance P on desensitization of the
nAChR (Stallcup and Patrick, 1980) is a rare case. Ac-
cording to current ideas, aBtx binds at a site that is
close to, but distinct from, the ACh binding site (Unwin,
1993). Does lynx1 bind at the same site, and does it
alter the binding of ACh or alter the channel properties
of the AChR?
Third, the location of lynx1 on the postsynaptic cell
surface is unusual for a neuroeffector peptide. One pos-
sibility is that it could act as a retrograde signal to nico-
tinic or other receptors on the presynaptic terminal to
modulate transmitter release. If true, this mechanism
would be novel and interesting, as the peptide would
presumably act only after proteolytic cleavage or, less
likely, by direct membrane contact. Alternatively, lynx1
might play a different role at the synapse, perhaps more
akin to Ly-6 in mediating adhesive or recognition func-
tions in lymphocytes.
Finally, one would like to know if lynx1 is found in
muscle cells or motor neurons, and if it acts at the neuro-
muscular junction. A physiological role for lynx1 at this
synapse would bring the a neurotoxin story full circle in
a historically fitting and entirely satisfying way.
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